Ningbo 2nd Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Fatty liver disease (MASLD/MASH)1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Eli Lilly and Company2 trials

Running trials

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Eli Lilly and Company· Source

  Contact: Hong shan Li (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)1 recruiting

Closed trials

• Withdrawn

  Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease

  NCT06598631· Phase 2· Eli Lilly and Company· Source